COVID-19 Pandemic Is Associated with an Adverse Impact on Burnout and Mood Disorder in Healthcare Professionals
Abstract
:1. Introduction
2. Participants and Methods
2.1. Study Design
2.2. Statistics
3. Results
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
COVID-19 | coronavirus disease 2019 |
ER | emergency room |
ICU | intensive care unit |
OPD | outpatient department |
References
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
- Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733. [Google Scholar] [CrossRef]
- Rothe, C.; Schunk, M.; Sothmann, P.; Bretzel, G.; Froeschl, G.; Wallrauch, C.; Zimmer, T.; Thiel, V.; Janke, C.; Guggemos, W.; et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020, 382, 970–971. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Helmy, Y.A.; Fawzy, M.; Elaswad, A.; Sobieh, A.; Kenney, S.P.; Shehata, A.A. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J. Clin. Med. 2020, 9, 1225. [Google Scholar] [CrossRef] [PubMed]
- Chan, J.F.; Yuan, S.; Kok, K.H.; To, K.K.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C.C.; Poon, R.W.; et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020, 395, 514–523. [Google Scholar] [CrossRef] [Green Version]
- Onder, G.; Rezza, G.; Brusaferro, S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020, 323, 1775–1776. [Google Scholar] [CrossRef] [PubMed]
- Guan, W.J.; Ni, Z.Y.; Hu, Y.; Liang, W.H.; Ou, C.Q.; He, J.X.; Liu, L.; Shan, H.; Lei, C.L.; Hui, D.S.C.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
- Wang, D.; Hu, B.; Hu, C.; Zhu, F.; Liu, X.; Zhang, J.; Wang, B.; Xiang, H.; Cheng, Z.; Xiong, Y.; et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020, 323, 1061–1069. [Google Scholar] [CrossRef]
- Cummings, M.J.; Baldwin, M.R.; Abrams, D.; Jacobson, S.D.; Meyer, B.J.; Balough, E.M.; Aaron, J.G.; Claassen, J.; Rabbani, L.E.; Hastie, J.; et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet 2020, 395, 1763–1770. [Google Scholar] [CrossRef]
- Pak, A.; Adegboye, O.A.; Adekunle, A.I.; Rahman, K.M.; McBryde, E.S.; Eisen, D.P. Economic Consequences of the COVID-19 Outbreak: The Need for Epidemic Preparedness. Front. Public Health 2020, 8, 241. [Google Scholar] [CrossRef]
- Lotfi, M.; Hamblin, M.R.; Rezaei, N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin. Chim. Acta 2020, 508, 254–266. [Google Scholar] [CrossRef]
- Guan, W.J.; Chen, R.C.; Zhong, N.S. Strategies for the prevention and management of coronavirus disease 2019. Eur. Respir. J. 2020, 55. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheng, H.Y.; Jian, S.W.; Liu, D.P.; Ng, T.C.; Huang, W.T.; Lin, H.H.; Taiwan, C.-O.I.T. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Intern. Med. 2020, 180, 1156–1163. [Google Scholar] [CrossRef]
- Cheng, S.C.; Chang, Y.C.; Fan Chiang, Y.L.; Chien, Y.C.; Cheng, M.; Yang, C.H.; Huang, C.H.; Hsu, Y.N. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J. Formos. Med. Assoc. 2020, 119, 747–751. [Google Scholar] [CrossRef]
- Cheng, H.Y.; Li, S.Y.; Yang, C.H. Initial rapid and proactive response for the COVID-19 outbreak—Taiwan’s experience. J. Formos. Med. Assoc. 2020, 119, 771–773. [Google Scholar] [CrossRef]
- Wang, C.J.; Ng, C.Y.; Brook, R.H. Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA 2020, 323, 1341–1342. [Google Scholar] [CrossRef]
- Kao, H.Y.; Ko, H.Y.; Guo, P.; Chen, C.H.; Chou, S.M. Taiwan’s Experience in Hospital Preparedness and Response for Emerging Infectious Diseases. Health Secur. 2017, 15, 175–184. [Google Scholar] [CrossRef] [PubMed]
- Chang, Y.T.; Lin, C.Y.; Tsai, M.J.; Hung, C.T.; Hsu, C.W.; Lu, P.L.; Hou, M.F. Infection control measures of a Taiwanese hospital to confront the COVID-19 pandemic. Kaohsiung J. Med. Sci. 2020, 36, 296–304. [Google Scholar] [CrossRef] [PubMed]
- Liang, Y.; Wu, K.; Zhou, Y.; Huang, X.; Zhou, Y.; Liu, Z. Mental Health in Frontline Medical Workers during the 2019 Novel Coronavirus Disease Epidemic in China: A Comparison with the General Population. Int. J. Environ. Res. Public Health 2020, 17, 6550. [Google Scholar] [CrossRef]
- Gold, J.A. Covid-19: Adverse mental health outcomes for healthcare workers. BMJ 2020, 369, m1815. [Google Scholar] [CrossRef]
- Alshekaili, M.; Hassan, W.; Al Said, N.; Al Sulaimani, F.; Jayapal, S.K.; Al-Mawali, A.; Chan, M.F.; Mahadevan, S.; Al-Adawi, S. Factors associated with mental health outcomes across healthcare settings in Oman during COVID-19: Frontline versus non-frontline healthcare workers. BMJ Open 2020, 10, e042030. [Google Scholar] [CrossRef] [PubMed]
- Cai, Q.; Feng, H.; Huang, J.; Wang, M.; Wang, Q.; Lu, X.; Xie, Y.; Wang, X.; Liu, Z.; Hou, B.; et al. The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control study. J. Affect. Disord. 2020, 275, 210–215. [Google Scholar] [CrossRef] [PubMed]
- Gao, J.; Zheng, P.; Jia, Y.; Chen, H.; Mao, Y.; Chen, S.; Wang, Y.; Fu, H.; Dai, J. Mental health problems and social media exposure during COVID-19 outbreak. PLoS ONE 2020, 15, e0231924. [Google Scholar] [CrossRef]
- Bao, Y.; Sun, Y.; Meng, S.; Shi, J.; Lu, L. 2019-nCoV epidemic: Address mental health care to empower society. Lancet 2020, 395, e37–e38. [Google Scholar] [CrossRef] [Green Version]
- Chang, C.M.; Tan, T.W.; Ho, T.C.; Chen, C.C.; Su, T.H.; Lin, C.Y. COVID-19: Taiwan’s epidemiological characteristics and public and hospital responses. PeerJ 2020, 8, e9360. [Google Scholar] [CrossRef]
- Yeh, W.Y.; Cheng, Y.; Chen, M.J.; Chiu, W.H. Development and validation of an occupational burnout inventory. Taiwan J. Public Health 2008, 27, 349–364. [Google Scholar]
- Yeh, W.Y.; Cheng, Y.; Chen, C.J.; Hu, P.Y.; Kristensen, T.S. Psychometric properties of the Chinese version of Copenhagen burnout inventory among employees in two companies in Taiwan. Int. J. Behav. Med. 2007, 14, 126–133. [Google Scholar] [CrossRef]
- Kristensen, T.S.; Borritz, M.; Villadsen, E.; Christensen, K.B. The Copenhagen Burnout Inventory: A new tool for the assessment of burnout. Work Stress 2005, 19, 192–207. [Google Scholar] [CrossRef]
- Lu, I.C.; Yen Jean, M.C.; Lei, S.M.; Cheng, H.H.; Wang, J.D. BSRS-5 (5-item Brief Symptom Rating Scale) scores affect every aspect of quality of life measured by WHOQOL-BREF in healthy workers. Qual. Life Res. 2011, 20, 1469–1475. [Google Scholar] [CrossRef] [Green Version]
- Lee, M.B.; Liao, S.C.; Lee, Y.J.; Wu, C.H.; Tseng, M.C.; Gau, S.F.; Rau, C.L. Development and verification of validity and reliability of a short screening instrument to identify psychiatric morbidity. J. Formos. Med. Assoc. 2003, 102, 687–694. [Google Scholar]
- Koutsimani, P.; Montgomery, A.; Georganta, K. The Relationship Between Burnout, Depression, and Anxiety: A Systematic Review and Meta-Analysis. Front. Psychol. 2019, 10, 284. [Google Scholar] [CrossRef] [Green Version]
- Lai, J.; Ma, S.; Wang, Y.; Cai, Z.; Hu, J.; Wei, N.; Wu, J.; Du, H.; Chen, T.; Li, R.; et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw. Open 2020, 3, e203976. [Google Scholar] [CrossRef] [PubMed]
- Lu, W.; Wang, H.; Lin, Y.; Li, L. Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study. Psychiatry Res. 2020, 288, 112936. [Google Scholar] [CrossRef] [PubMed]
- Barrett, E.S.; Horton, D.B.; Roy, J.; Gennaro, M.L.; Brooks, A.; Tischfield, J.; Greenberg, P.; Andrews, T.; Jagpal, S.; Reilly, N.; et al. Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic. BMC Infect. Dis. 2020, 20, 853. [Google Scholar] [CrossRef]
- An, Y.; Yang, Y.; Wang, A.; Li, Y.; Zhang, Q.; Cheung, T.; Ungvari, G.S.; Qin, M.Z.; An, F.R.; Xiang, Y.T. Prevalence of depression and its impact on quality of life among frontline nurses in emergency departments during the COVID-19 outbreak. J. Affect. Disord. 2020, 276, 312–315. [Google Scholar] [CrossRef]
- Bai, Y.; Lin, C.C.; Lin, C.Y.; Chen, J.Y.; Chue, C.M.; Chou, P. Survey of stress reactions among health care workers involved with the SARS outbreak. Psychiatr Serv. 2004, 55, 1055–1057. [Google Scholar] [CrossRef] [PubMed]
- Brooks, S.K.; Dunn, R.; Amlot, R.; Rubin, G.J.; Greenberg, N. A Systematic, Thematic Review of Social and Occupational Factors Associated With Psychological Outcomes in Healthcare Employees During an Infectious Disease Outbreak. J. Occup. Environ. Med. 2018, 60, 248–257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brooks, S.K.; Webster, R.K.; Smith, L.E.; Woodland, L.; Wessely, S.; Greenberg, N.; Rubin, G.J. The psychological impact of quarantine and how to reduce it: Rapid review of the evidence. Lancet 2020, 395, 912–920. [Google Scholar] [CrossRef] [Green Version]
- Tsai, Y.C.; Liu, C.H. Factors and symptoms associated with work stress and health-promoting lifestyles among hospital staff: A pilot study in Taiwan. BMC Health Serv. Res. 2012, 12, 199. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jackson, L.A.; Anderson, E.J.; Rouphael, N.G.; Roberts, P.C.; Makhene, M.; Coler, R.N.; McCullough, M.P.; Chappell, J.D.; Denison, M.R.; Stevens, L.J.; et al. An mRNA Vaccine against SARS-CoV-2—Preliminary Report. N. Engl. J. Med. 2020, 383, 1920–1931. [Google Scholar] [CrossRef]
- Folegatti, P.M.; Ewer, K.J.; Aley, P.K.; Angus, B.; Becker, S.; Belij-Rammerstorfer, S.; Bellamy, D.; Bibi, S.; Bittaye, M.; Clutterbuck, E.A.; et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 2020, 396, 467–478. [Google Scholar] [CrossRef]
- Zhu, F.C.; Li, Y.H.; Guan, X.H.; Hou, L.H.; Wang, W.J.; Li, J.X.; Wu, S.P.; Wang, B.S.; Wang, Z.; Wang, L.; et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 2020, 395, 1845–1854. [Google Scholar] [CrossRef]
- Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021, 384, 403–416. [Google Scholar] [CrossRef] [PubMed]
Groups | All (n = 2029) | No/Minimal (n = 1379) | Mild (n = 379) | Moderate (n = 227) | Severe (n = 44) | p-Value |
---|---|---|---|---|---|---|
Gender | 0.66 | |||||
Male (n, %) | 355 (17.5) | 245 (69.0) | 60 (16.9) | 40 (11.3) | 10 (2.9) | |
Female (n, %) | 1674 (82.5) | 1134 (67.7) | 319 (19.1) | 187 (11.2) | 34 (2.0) | |
Age (mean ± SD) | 40.4 ± 10.05 | 40.7 ± 10.44 | 40.0 ± 9.14 | 39.46 ± 9.07 | 38.27 ± 9.04 | |
Age subgroup (years) | 0.005 | |||||
21–30 (n, %) | 423 (20.8) | 294 (69.5) | 73 (17.3) | 43 (10.1) | 13 (3.1) | |
31–40 (n, %) | 621 (30.6) | 400 (64.4) | 124 (20.0) | 86 (13.8) | 11 (1.8) | |
41–50 (n, %) | 627 (30.9) | 411 (65.6) | 132 (21.1) | 69 (11.0) | 15 (2.4) | |
>50 (n, %) | 358 (17.6) | 274 (76.5) | 50 (14.0) | 29 (8.1) | 5 (1.4) | |
Category group | <0.0001 | |||||
Physician (n, %) | 142 (7.0) | 107 (75.4) | 22 (15.5) | 10 (7.0) | 3 (2.1) | |
Nurse (n, %) | 901 (44.4) | 561 (62.3) | 190 (21.1) | 125 (13.9) | 25 (2.7) | |
Medical staff (n, %) | 384 (18.9) | 295 (76.8) | 52 (13.5) | 31 (8.1) | 6 (1.6) | |
Technician (n, %) | 69 (3.4) | 46 (66.7) | 12 (17.4) | 9 (13.0) | 2 (2.9) | |
Administration (n, %) | 533 (26.3) | 370 (69.4) | 103 (19.3) | 52 (9.8) | 8 (1.5) | |
Patient contact | 0.081 | |||||
Yes (n, %) | 1491 (73.5) | 994 (66.7) | 287 (19.2) | 172 (11.5) | 38 (2.6) | |
No (n, %) | 538 (26.5) | 385 (71.6) | 92 (17.1) | 55 (10.2) | 6 (1.1) | |
Working space/area | <0.0001 | |||||
Emergency room (n, %) | 90 (4.4) | 51 (56.7) | 17 (18.9) | 20 (22.2) | 2 (2.2) | |
ICU/isolation wards (n, %) | 193 (9.5) | 116 (60.1) | 41 (21.2) | 27 (14.0) | 9 (4.7) | |
General wards (n, %) | 517 (25.5) | 332 (64.2) | 105 (20.3) | 67 (13.0) | 13 (2.5) | |
OPD/exam rooms (n, %) | 441 (21.7) | 320 (72.6) | 81 (18.4) | 32 (7.3) | 8 (1.8) | |
RnC/PS/P (n, %) | 98 (4.8) | 80 (81.6) | 10 (10.2) | 5 (5.1) | 3 (3.1) | |
Administrative area (n, %) | 297 (14.6) | 201 (67.7) | 59 (19.9) | 34 (11.4) | 3 (1.0) | |
Others (n, %) | 393 (19.4) | 279 (71.0) | 66 (16.8) | 42 (10.7) | 6 (1.5) | |
Extra working hours during COVID-19 pandemic | 0.73 | |||||
No (n, %) | 1201 (59.2) | 822 (68.4) | 217 (18.1) | 140 (11.7) | 22 (1.8) | |
<10 h (n, %) | 783 (38.6) | 526 (67.2) | 155 (19.8) | 81 (10.3) | 21 (2.7) | |
≥10 h (n, %) | 45 (2.2) | 31 (68.9) | 7 (15.6) | 6 (13.3) | 1 (2.2) |
Groups | All (n = 2029) | No/Minimal (n = 1379) | Mild (n = 379) | Moderate (n = 227) | Severe (n = 44) | p-Value |
---|---|---|---|---|---|---|
Personal burnout score (mean ± SD) | 45.38 ± 19.44 | 38.59 ± 16.20 | 54.85 ± 15.15 | 64.39 ± 18.11 | 78.31 ± 19.53 | |
Personal burnout severity | <0.0001 | |||||
No (n, %) | 38 (1.9) | 38 (100) | 0 (0) | 0 (0) | 0 (0) | |
Mild (n, %) | 1090 (53.7) | 952 (87.3) | 107 (9.8) | 28 (2.6) | 3 (0.3) | |
Moderate (n, %) | 645 (31.8) | 339 (52.6) | 193 (29.9) | 106 (16.4) | 7 (1.1) | |
Severe (n, %) | 256 (12.6) | 50 (19.5) | 79 (30.9) | 93 (36.3) | 34 (13.3) | |
Work-related burnout score (mean ± SD) | 42.78 ± 17.68 | 36.59 ± 15.03 | 51.48 ± 12.77 | 59.94 ± 15.79 | 73.29 ± 19.23 | |
Work-related burnout severity | <0.0001 | |||||
No (n, %) | 20 (1.0) | 19 (95.0) | 0 (0) | 0 (0) | 1 (5.0) | |
Mild (n, %) | 1086 (53.5) | 941 (86.6) | 110 (10.2) | 34 (3.1) | 1 (0.1) | |
Moderate (n, %) | 612 (30.2) | 347 (56.7) | 173 (28.2) | 86 (14.1) | 6 (1.0) | |
Severe (n, %) | 311 (15.3) | 72 (23.2) | 96 (30.9) | 107 (34.4) | 36 (11.6) |
Variables | Crude OR 95%CI | p-Value | Adjusted OR 95%CI | p-Value |
---|---|---|---|---|
Gender group | ||||
Male | 1 (Ref.) | |||
Female | 1.08 (0.77–1.50) | 0.657 | ||
Age subgroup (years) | ||||
21–30 | 1 (Ref.) | |||
31–40 | 1.21 (0.85–1.73) | 0.286 | ||
41–50 | 1.01 (0.71–1.46) | 0.941 | ||
>50 | 0.69 (0.44–1.08) | 0.104 | ||
Category group | ||||
Physician | 1 (Ref.) | 1 (Ref.) | ||
Nurse | 1.98 (1.09–3.59) | 0.025 | 1.70 (0.97–3.11) | 0.087 |
Medical staff | 1.06 (0.54–2.05) | 0.868 | 1.07 (0.54–2.12) | 0.857 |
Technician | 1.88 (0.80–4.45) | 0.150 | 1.75 (0.72–4.28) | 0.220 |
Administration | 1.26 (0.67–2.36) | 0.474 | 1.07 (0.54–2.14) | 0.847 |
Patient contact | ||||
No | 1 (Ref.) | |||
Yes | 1.282(0.946–1.737) | 0.109 | ||
Working space/area | ||||
RnC/PS/P | 1 (Ref.) | 1 (Ref.) | ||
ER | 3.64 (1.53–8.67) | 0.004 | 2.81 (1.14–6.90) | 0.024 |
ICU/isolation wards | 2.58 (1.15–5.79) | 0.022 | 1.78 (0.75–4.19) | 0.189 |
General wards | 2.51 (0.96–4.41) | 0.063 | 1.45 (0.641–3.30) | 0.371 |
OPD/exam rooms | 1.12 (0.51–2.48) | 0.776 | 0.90 (0.40–2.08) | 0.809 |
Administrative area | 1.60 (0.72–3.57) | 0.249 | 1.54 (0.66–3.56) | 0.315 |
Others | 1.57 (0.72–3.43) | 0.262 | 1.28 (0.57–2.85) | 0.554 |
Extra duty for COVID-19 | ||||
No | 1 (Ref.) | |||
Yes | 1.038 (0.803–1.341) | 0.778 |
Overall | 2019 (n = 3021) | 2020 (n = 2029) | p-Value |
---|---|---|---|
Personal burnout score (mean ± SD) | 39.04 ± 20.62 | 45.38 ± 19.44 | <0.0001 |
Personal burnout severity groups | <0.0001 | ||
No (n, %) | 133 (4.4) | 38 (1.9) | |
Mild (n, %) | 1916 (63.2) | 1090 (53.7) | |
Moderate (n, %) | 716 (23.7) | 645 (31.8) | |
Severe (n, %) | 256 (8.5) | 256 (12.6) | |
Work-related burnout score (mean ± SD) | 43.24 ± 12.26 | 42.78 ± 17.68 | 0.279 |
Work-related burnout severity | <0.0001 | ||
No (n, %) | 0 | 20 (1.0) | |
Mild (n, %) | 1656 (54.8) | 1086 (53.5) | |
Moderate (n, %) | 1089 (36.1) | 612 (30.2) | |
Severe (n, %) | 276 (9.1) | 311 (15.3) | |
Participant with moderate/severe mood disorder in 2020 (also completed 2019 survey) | 2019 | 2020 | |
Personal burnout score (mean ± SD) | 48.80 ± 21.49 | 66.68 ± 19.94 | <0.0001 |
Personal burnout severity groups | <0.0001 | ||
No (n, %) | 4 (2.1) | 0 | |
Mild (n, %) | 93 (48.2) | 24 (12.4) | |
Moderate (n, %) | 59 (30.6) | 80 (41.5) | |
Severe (n, %) | 37 (19.1) | 89 (46.1) | |
Work-related burnout score (mean ± SD) | 48.65 ± 13.07 | 62.10 ± 17.49 | <0.0001 # |
Work-related burnout severity | <0.0001 | ||
No (n, %) | 0 | 1 (0.5) | |
Mild (n, %) | 72 (37.3) | 28 (14.5) | |
Moderate (n, %) | 81 (42.0) | 63 (32.6) | |
Severe (n, %) | 40 (20.7) | 101 (52.3) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lin, Y.-Y.; Pan, Y.-A.; Hsieh, Y.-L.; Hsieh, M.-H.; Chuang, Y.-S.; Hsu, H.-Y.; Huang, Y.-H.; Hsu, C.-E.; Cheng, Y.-C.; Cho, S.-F.; et al. COVID-19 Pandemic Is Associated with an Adverse Impact on Burnout and Mood Disorder in Healthcare Professionals. Int. J. Environ. Res. Public Health 2021, 18, 3654. https://doi.org/10.3390/ijerph18073654
Lin Y-Y, Pan Y-A, Hsieh Y-L, Hsieh M-H, Chuang Y-S, Hsu H-Y, Huang Y-H, Hsu C-E, Cheng Y-C, Cho S-F, et al. COVID-19 Pandemic Is Associated with an Adverse Impact on Burnout and Mood Disorder in Healthcare Professionals. International Journal of Environmental Research and Public Health. 2021; 18(7):3654. https://doi.org/10.3390/ijerph18073654
Chicago/Turabian StyleLin, Yu-Yin, Yu-An Pan, Yi-Ling Hsieh, Meng-Hsuan Hsieh, Yun-Shiuan Chuang, Hsiu-Yi Hsu, Ya-Hsiu Huang, Chia-En Hsu, Yi-Chen Cheng, Shih-Feng Cho, and et al. 2021. "COVID-19 Pandemic Is Associated with an Adverse Impact on Burnout and Mood Disorder in Healthcare Professionals" International Journal of Environmental Research and Public Health 18, no. 7: 3654. https://doi.org/10.3390/ijerph18073654
APA StyleLin, Y. -Y., Pan, Y. -A., Hsieh, Y. -L., Hsieh, M. -H., Chuang, Y. -S., Hsu, H. -Y., Huang, Y. -H., Hsu, C. -E., Cheng, Y. -C., Cho, S. -F., & Wang, C. -L. (2021). COVID-19 Pandemic Is Associated with an Adverse Impact on Burnout and Mood Disorder in Healthcare Professionals. International Journal of Environmental Research and Public Health, 18(7), 3654. https://doi.org/10.3390/ijerph18073654